Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Cytokine mediators of chronic graft-versus-host disease
Kelli P.A. MacDonald, … , Bruce R. Blazar, Geoffrey R. Hill
Kelli P.A. MacDonald, … , Bruce R. Blazar, Geoffrey R. Hill
Published June 30, 2017
Citation Information: J Clin Invest. 2017;127(7):2452-2463. https://doi.org/10.1172/JCI90593.
View: Text | PDF
Review Series

Cytokine mediators of chronic graft-versus-host disease

  • Text
  • PDF
Abstract

Substantial preclinical and clinical research into chronic graft-versus-host disease (cGVHD) has come to fruition in the last five years, generating a clear understanding of a complex cytokine-driven cellular network. cGVHD is mediated by naive T cells differentiating within IL-17–secreting T cell and follicular Th cell paradigms to generate IL-21 and IL-17A, which drive pathogenic germinal center (GC) B cell reactions and monocyte-macrophage differentiation, respectively. cGVHD pathogenesis includes thymic damage, impaired antigen presentation, and a failure in IL-2–dependent Treg homeostasis. Pathogenic GC B cell and macrophage reactions culminate in antibody formation and TGF-β secretion, respectively, leading to fibrosis. This new understanding permits the design of rational cytokine and intracellular signaling pathway–targeted therapeutics, reviewed herein.

Authors

Kelli P.A. MacDonald, Bruce R. Blazar, Geoffrey R. Hill

×

Figure 2

Overview of the cytokine-driven cellular network driving cGVHD.

Options: View larger image (or click on image) Download as PowerPoint
Overview of the cytokine-driven cellular network driving cGVHD.
cGVHD is...
cGVHD is now recognized as a Th17/Tc17- and Tfh-mediated disease. DC priming of naive allogeneic T cells in the setting of elevated IL-6 production after BMT drives RORγt expression and Th17/Tc17 differentiation and accumulation in target tissues. Increased Tfh, GC B cells, and antibody, which accumulate in target tissues, contribute to cGVHD pathology. Tfh express high levels of IL-21, which, together with elevated levels of BAFF, drive GC B cell formation and antibody secretion. CSF-1–dependent macrophages are late-phase mediators of cGVHD pathology. Th17/Tc17 are polyfunctional and coexpress high levels of multiple cytokines, including IFN-γ, TNF, IL-22, CSF-1, and GM-CSF, which are implicated in promoting the migration and differentiation of Ly6Clo monocytes into pathogenic M2 macrophages. Plasma cell–derived allo- and autoantibodies can bind to Fc receptors on macrophages, potentially contributing to their polarization. Through their secretion of TGF-β, Ly6Clo-derived macrophages promote fibroblast activation and collagen production, leading to tissue fibrosis. Adapted with permission from Blood (11).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts